IFRS 17 implementation is finished. IFRS 17 analytics has barely started. The insurers that treat phase two as a software upgrade rather than a reporting refresh will discover, slowly and expensively, that the standard’s value is in the explanation — not the journal entry.

By Meyr Kruger, FASSA, Actuary

For insurers reporting under IFRS, IFRS 17 is now an operating model rather than a project. The standard became effective for annual reporting periods beginning on or after 1 January 2023. The challenge after go-live is different: how to explain performance under IFRS 17 in a way that is accurate, consistent, timely and useful to boards, investors, regulators and management.

Why it remains hard

IFRS 17 introduced a current measurement model, the contractual service margin, risk adjustment, onerous-contract assessment, new insurance revenue concepts, discounting and extensive disclosures. It aims to improve transparency and comparability. The operating reality is that insurers still make judgements about groups of contracts, coverage units, discount rates, risk adjustment, expense attribution, reinsurance treatment, transition, experience variances and assumption changes — and even where companies comply with the same standard, differences in judgement and disclosure can make comparison genuinely difficult.

Thorpe’s 2025 South African analysis of large listed financial services groups puts this directly: IFRS 17 provides a new lens, but technical actuarial disclosure items require careful interpretation before results are directly comparable. That is the unresolved phase-two problem.

The five analytics that change the conversation

CSM analytics. The CSM is the most important IFRS 17 metric for life insurers. Management needs to understand new business CSM, release, assumption changes, experience adjustments, onerous losses, interest accretion and reinsurance effects. A good analytics layer reconciles CSM movements to actuarial model outputs, finance ledgers and management commentary — in one view.

Risk adjustment analytics. Risk adjustment is judgemental and difficult to compare across companies. Analytics should explain methodology, confidence levels or equivalent measures, diversification, release patterns and sensitivity.

Insurance revenue and service result. IFRS 17 changes how insurers present revenue and profit emergence. Business stakeholders need bridges from embedded value, value of new business, statutory profit, management accounts and IFRS 17 performance — and the bridges should be reproducible, not rebuilt every quarter.

Assumption-change attribution. Management needs to know why results moved. The attribution should distinguish economic, demographic, expense, lapse, claims, mortality, morbidity and operating changes — not lump them into a single residual.

Automation and close acceleration. IFRS 17 reporting involves large data volumes, multiple systems and tight timelines. Manual spreadsheets increase operational risk and erode the close. Controlled automation of data ingestion, model runs, reconciliations, journals, disclosure tables and management packs is the next step. Where AI tools support that automation, the controls on our How we use AI page apply.

What the wider market is finding

CAS research on IFRS 17 implementation for general insurers in Asia documents emerging practices and challenges around the Premium Allocation Approach, with survey evidence from live jurisdictions. KPMG’s 2026 analysis of 55 insurers reporting under IFRS 17 notes growing maturity in accounting policies and disclosures alongside ongoing refinement. The Actuaries Institute’s post-implementation survey shows continuing interest in how IFRS 17 is applied and understood after go-live.

The pattern is consistent across all three: implementation was phase one. Phase two is better analytics, better controls and better explanation — and the insurers that win are the ones that recognise the difference.

What a mature IFRS 17 analytics platform supports

  • data lineage from source systems to disclosure;
  • model-run control and reproducibility;
  • CSM movement analysis;
  • risk-adjustment analysis;
  • actual-versus-expected results;
  • onerous-contract monitoring;
  • discount-rate and economic sensitivity;
  • assumption-change attribution;
  • finance-actuarial reconciliations;
  • audit trail and evidence packs;
  • board and investor reporting;
  • scenario and planning analytics.

The goal is not only compliance. It is using IFRS 17 information to understand business performance.

South African insurers, specifically

South African insurers have already invested heavily in IFRS 17 implementation. The next opportunity is to convert that investment into better decision support — faster reporting, clearer explanation of earnings, better assumption governance and more useful management dashboards. For listed groups, comparability and investor communication remain important. For unlisted insurers, operational control and management insight may be the larger value driver. Both groups face the same underlying engineering question: can the actuarial-finance pipeline be reproduced, monitored and explained at speed?

The shift to name

IFRS 17 has moved into its analytics era. The insurers that benefit most will be those that can turn complex actuarial-finance calculations into controlled, explainable and decision-useful information. The capability is not only an actuarial model or an accounting engine. It is an integrated workflow that connects data, assumptions, models, controls, reporting and commentary in one place — and that is where modern actuarial technology earns its return.

If you are moving from IFRS 17 compliance to IFRS 17 analytics, our Finance Modernisation practice covers the close-acceleration, attribution and disclosure work as a single engagement.

Sources